A new crop of drug-resistant superbugs is in our midst, and experts believe that they could rival the deadly superbug MRSA. A new report from the Infectious Diseases Society of America says these ...

Finding effective new medicines, especially against hard-to-treat Gram-negative bacteria, is critical. Now, a recent discovery might offer hope, thanks to researchers at McMaster University who ...

More than 4.5 million deaths occurred due to antibiotic resistance in 2019. The World Health Organization (WHO) has designated Gram-negative bacteria as a critical threat because of their ability ...

Thus, formed colistin is active against MDR bacteria and CMS is an inactive ... most discussed alternatives for the treatment of MDR Gram-negative bacterial infection. The usefulness of colistin ...

But it will apply selective pressure to the Gram negative bacteria of your microbiota, promoting survival and success of those with resistance to monobactams that may cause problems in the future ...

Doripenem, a member of the β-lactam class of antibiotics ... bactericidal activity against gram-positive bacteria; enteric and nonenteric gram-negative bacteria, including extended-spectrum ...

That process led to the group discovering a lasso peptide that exhibited broad-spectrum antibiotic activity and was effective at killing both gram-positive and gram-negative pathogenic bacteria, along ...

Iterum Therapeutics plc (Nasdaq: ITRM), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and ...

For millions of years, frogs have flourished in microbial swamps yet rarely falling ill. To survive these hostile environments, they evolved potent chemical defenses. Now, scientists are learning to ...

The QIDP status, granted by USFDA makes VRP-034 eligible for regulatory benefits including priority FDA review, potential ...